227 related articles for article (PubMed ID: 34812072)
21. Differential diagnosis of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma by cytological analysis.
Sugiyama K; Washimi K; Sato S; Hiruma T; Sakai M; Okubo Y; Miyagi Y; Yokose T
Diagn Cytopathol; 2022 Mar; 50(3):112-122. PubMed ID: 34984861
[TBL] [Abstract][Full Text] [Related]
22. Intra-Abdominal and Retroperitoneal Benign Lipomatous Tumors-An Extremely Rare Mimic of Liposarcoma and its Diagnostic Challenge.
Malik F; Allbee AW; Zhang PJ
Int J Surg Pathol; 2024 Feb; 32(1):46-57. PubMed ID: 37131332
[No Abstract] [Full Text] [Related]
23. Atypical Spindle Cell Lipomatous Tumor: Clinicopathologic Characterization of 232 Cases Demonstrating a Morphologic Spectrum.
Mariño-Enriquez A; Nascimento AF; Ligon AH; Liang C; Fletcher CD
Am J Surg Pathol; 2017 Feb; 41(2):234-244. PubMed ID: 27879515
[TBL] [Abstract][Full Text] [Related]
24. Atypical spindle cell/pleomorphic lipomatous tumor with a sarcomatous component showing high mitotic activity and Ki-67 labeling index: report of a unique case mimicking dedifferentiated liposarcoma.
Sugita S; Sugawara T; Emori M; Aoyama T; Hosaka M; Segawa K; Fujita H; Hasegawa T
Med Mol Morphol; 2022 Dec; 55(4):323-328. PubMed ID: 35779129
[TBL] [Abstract][Full Text] [Related]
25. Retroperitoneal Well-Differentiated Liposarcoma With Uterine-Type Leiomyomatous Differentiation: A First Case Report With Literature Analysis of Soft Tissue Sarcomas With Dual Lipomatous and Low-Grade Smooth Muscle Differentiation.
Tran TAN; de La Fuente S
Int J Surg Pathol; 2019 Oct; 27(7):798-803. PubMed ID: 31131653
[TBL] [Abstract][Full Text] [Related]
26. "Fat-Rich" (Spindle Cell-Poor) Variant of Atypical Spindle Cell/Pleomorphic Lipomatous Tumor: Striking Mimic of "Classical" Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma.
Creytens D; Mentzel T; Ferdinande L; van Gorp J; Van Dorpe J; Flucke U
Int J Surg Pathol; 2019 Dec; 27(8):868-871. PubMed ID: 31131655
[TBL] [Abstract][Full Text] [Related]
27. Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors.
Suster S; Fisher C
Am J Surg Pathol; 1997 Feb; 21(2):195-200. PubMed ID: 9042286
[TBL] [Abstract][Full Text] [Related]
28. MDM4 amplification in atypical lipomatous tumors/well-differentiated liposarcoma: Private event or alternative oncogenic mechanism?
Gruel N; El Zein S; Tzanis D; Nicolas N; Maraval A; Fieffe C; Bonvalot S; Caly M; Fuhrmann L; Ait Rais K; Jovelin S; Bonnet C; Pierron G; Watson S
Genes Chromosomes Cancer; 2023 Jun; 62(6):367-372. PubMed ID: 36744846
[TBL] [Abstract][Full Text] [Related]
29. Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/ well differentiated liposarcoma.
Machado I; Vargas AC; Maclean F; Llombart-Bosch A
Pathol Res Pract; 2022 Apr; 232():153839. PubMed ID: 35303521
[TBL] [Abstract][Full Text] [Related]
30. Image-Guided Core Needle Biopsy of Adipocytic Tumors: Diagnostic Accuracy and Concordance With Final Surgical Pathology.
Thavikulwat AC; Wu JS; Chen X; Anderson ME; Ward A; Kung J
AJR Am J Roentgenol; 2021 Apr; 216(4):997-1002. PubMed ID: 33624523
[No Abstract] [Full Text] [Related]
31. Atypical lipomatous tumor/"well-differentiated liposarcoma" of the skin clinically presenting as a skin tag: clinicopathologic, immunohistochemical, and molecular analysis of 2 cases.
Paredes BE; Mentzel T
Am J Dermatopathol; 2011 Aug; 33(6):603-7. PubMed ID: 21358383
[TBL] [Abstract][Full Text] [Related]
32. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
[TBL] [Abstract][Full Text] [Related]
33. [Lipoma and atypical lipomatous tumor within the same neoplasia: Evidence for a continuous transition].
Kuhnen C; Mentzel T; Lehnhardt M; Homann HH; Sciot R; Debiec-Rychter M
Pathologe; 2010 Mar; 31(2):129-34. PubMed ID: 20063101
[TBL] [Abstract][Full Text] [Related]
34. MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification.
Brisson M; Kashima T; Delaney D; Tirabosco R; Clarke A; Cro S; Flanagan AM; O'Donnell P
Skeletal Radiol; 2013 May; 42(5):635-47. PubMed ID: 22987247
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic importance of clinicopathologic features and p16, CD34, MDM2 expression in differential diagnosis of adipocytic tumors.
Altun E; Yüksel S; Kaygusuz G; Yıldız HY
Acta Orthop Traumatol Turc; 2020 Jan; 54(1):59-65. PubMed ID: 32175898
[TBL] [Abstract][Full Text] [Related]
36. Case report: Atypical spindle cell/pleomorphic lipomatous tumor masquerading as a myxoid liposarcoma or intramuscular myxoma.
Ichikawa J; Kawasaki T; Imada H; Kanno S; Taniguchi N; Ashizawa T; Haro H
Front Oncol; 2022; 12():1033114. PubMed ID: 36439417
[TBL] [Abstract][Full Text] [Related]
37. Update on Lipomatous Tumors with Emphasis on Emerging Entities, Unusual Anatomic Sites, and Variant Histologic Patterns.
Chrisinger JSA
Surg Pathol Clin; 2019 Mar; 12(1):21-33. PubMed ID: 30709444
[TBL] [Abstract][Full Text] [Related]
38. Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
Alshenawy H
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1073-81. PubMed ID: 23529275
[TBL] [Abstract][Full Text] [Related]
39. p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome.
Debelenko LV; Perez-Atayde AR; Dubois SG; Grier HE; Pai SY; Shamberger RC; Kozakewich HP
Pediatr Dev Pathol; 2010; 13(3):218-24. PubMed ID: 20028212
[TBL] [Abstract][Full Text] [Related]
40. Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status.
Knebel C; Neumann J; Schwaiger BJ; Karampinos DC; Pfeiffer D; Specht K; Lenze U; von Eisenhart-Rothe R; Rummeny EJ; Woertler K; Gersing AS
BMC Cancer; 2019 Apr; 19(1):309. PubMed ID: 30943944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
